A Prospective Cohort Study of Elevated Serum NLRP1 Levels to Prognosticate Neurological Outcome After Acute Intracerebral Hemorrhage at a Single Academic Institution
Wei Li,Jun Wang,Chao Tang,Xuan Lv,Suijun Zhu
DOI: https://doi.org/10.2147/ndt.s455049
IF: 2.989
2024-03-30
Neuropsychiatric Disease and Treatment
Abstract:Wei Li, 1, 2 Jun Wang, 1, 2 Chao Tang, 1, 2 Xuan Lv, 1, 2 Suijun Zhu 1, 2 1 Department of Neurosurgery, First People's Hospital of Linping District, Hangzhou, People's Republic of China; 2 Department of Neurosurgery, Linping Campus, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, People's Republic of China Correspondence: Suijun Zhu, Department of Neurosurgery, First People's Hospital of Linping District, Hangzhou, People's Republic of China, Email Background: Nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 1 (NLRP1) participates in neuroinflammation. This study aimed to identify serum NLRP as a potential prognostic biomarker of acute intracerebral hemorrhage (ICH). Methods: This prospective cohort study enrolled 145 patients with supratentorial ICH and 51 healthy controls. Serum NLRP1 levels were quantified on admission of all 145 patients, on days 1, 3, 5, 7, and 10 after stroke in 51 of 145 patients and at entry into the study of controls. Poststroke 6-month modified Rankin Scale (mRS) scores of 3– 6 signified a poor prognosis. Results: Compared to controls, patients had prominently increased serum NLRP1 levels until day 10 after ICH, with the highest levels at days 1 and 3. Serum NLRP1 levels were independently correlated with National Institutes of Health Stroke Scale (NIHSS) scores, hematoma volume and six-month mRS scores, and independently predicted six-month bad prognosis. A linear relationship was observed between serum NLRP1 levels and the risk of poor prognosis in a restricted cubic spline. Under the receiver operating characteristic (ROC) curve, serum NLRP levels efficiently discriminated poor prognosis. Serum NLRP1, NIHSS, and hematoma volume were merged into a prognosis prediction model, which was portrayed using a nomogram. Good performance of the model was verified using calibration curve, decision curve, and ROC curve. Conclusion: Serum NLRP1 levels are elevated during the early period following ICH and are independently related to hemorrhagic severity and poor prognosis, suggesting that serum NLRP1 may represent a promising prognostic biomarker of ICH. Keywords: intracerebral hemorrhage, NLRP1, prognosis, severity, biomarkers Spontaneous intracerebral hemorrhage (ICH) is a sort of very common cerebrovascular disorder that primarily affects the brain tissue surrounding the bleeding site and even remote locations in cases of intraventricular or subarachnoid extension. 1 In China, the estimated prevalence, incidence, mortality rate, disability rate, recurrence rate of stroke are still high since 2015. 2,3 Also, ICH has a high mortality and disability rate among survivors. 4 Primary ICH is a multifactorial disease, with hypertension and cerebral amyloid angiopathy being the two main causes. 5 Extensive research has yielded valuable insights into the pathophysiological mechanisms of secondary brain injury following ICH, highlighting the importance of inflammatory responses, oxidative stress reactions, and cellular death. 6–8 Some severity scales, such as the National Institutes of Health Stroke Scale (NIHSS) and hematoma volume, have been used clinically for ICH. 9–11 Notably, there is a growing amount of data showing that the detection of some valuable biomarkers can delve into the mechanisms of disease progression and aid in the severity evaluation and prognosis prediction of ICH. 12–16 Inflammasomes are critical components of the early innate inflammatory response to injury. 17–19 The nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 1 (NLRP1) inflammasome can activate caspase-1 and promote maturation of the inflammatory cytokine interleukin-1β and interleukin-18 mature, thereby augmenting the inflammatory response. 20–22 By amplifying neuroinflammation, damaging the blood–brain barrier, increasing brain edema, and eliciting neuronal apoptosis, NLRP1 may participate in acute brain injury, including ICH. 23–27 Upregulation of NLRP1 expression has been shown in animal cerebral cortices injured by ICH, subarachnoid hemorrhage, ischemia and trauma. 23–27 In humans with aneurysmal subarachnoid hemorrhage or traumatic brain injury, NLRP1 expression in the cerebrospinal fluid is highly associated with poor prognosis. 28,29 Likewise, serum NLRP1 levels were substantially elevated after acute ischemic stroke, which independently predicted poor prognosis three months after injury. 30 Thus, serum NLRP1 may serve as a biomarker of acute brain injury. To the bes -Abstract Truncated-
psychiatry,clinical neurology